Patents by Inventor Melanie Janelle Bevill

Melanie Janelle Bevill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COCRYSTALS OF PROGESTERONE
    Publication number: 20140235595
    Abstract: Disclosed herein are cocrystals of progesterone and a coformer containing a six-membered aromatic ring having at least one substituent possessing a carbonyl functionality. Cocrystals of progesterone and a coformer selected from vanillic acid, benzoic acid, salicylic acid, cinnamic acid, or vanillin are also disclosed herein.
    Type: Application
    Filed: September 4, 2013
    Publication date: August 21, 2014
    Applicant: Aptuit, Inc.
    Inventors: Ekaterina ALBERT, Patricia ANDRES, Melanie Janelle BEVILL, Jared SMIT, Jennifer NELSON
  • Forms of rifaximin and uses thereof
    Patent number: 8754098
    Abstract: The present invention relates to Rifaximin polymorphic, salt, hydrate, and amorphous forms, to their use in medicinal preparations and to therapeutic methods using them.
    Type: Grant
    Filed: August 23, 2012
    Date of Patent: June 17, 2014
    Assignee: Salix Pharmaceuticals, Ltd.
    Inventors: Karen S. Gushurst, Donglai Yang, Melanie Janelle Bevill, Nathan Carl Schultheiss, Petinka Vlahova, Jeffrey S. Stults, Travis L. Houston
  • COCRYSTALS OF P-COUMARIC ACID
    Publication number: 20140073674
    Abstract: Disclosed herein are cocrystals of p-coumaric acid and nicotinamide. A 1:1 molar ratio and a 2:1 molar ratio of p-coumaric acid to nicotinamide are herein disclosed.
    Type: Application
    Filed: September 4, 2013
    Publication date: March 13, 2014
    Applicant: Aptuit, Inc.
    Inventors: Melanie Janelle BEVILL, Nate SCHULTHEISS
  • FORMS OF RIFAXIMIN AND USES THEREOF
    Publication number: 20140011828
    Abstract: The present invention relates to Rifaximin amorphous forms, to their use in medicinal preparations and to therapeutic methods using them.
    Type: Application
    Filed: October 3, 2012
    Publication date: January 9, 2014
    Inventors: Karen S. Gushurst, Donglai Yang, Melanie Janelle Bevill, Nathan Carl Schultheiss, Giuseppe Claudio Viscomi
  • NEW FORMS OF RIFAXIMIN AND USES THEROF
    Publication number: 20130317225
    Abstract: The present invention relates to new rifaximin forms kappa, theta, rifaximin:piperazine cocrystal 1 and rifaximin:piperazine cocrystal 2, methods of making same and to their use in medicinal preparations and therapeutic methods.
    Type: Application
    Filed: July 31, 2013
    Publication date: November 28, 2013
    Inventors: Yiduo Wu, Stephan D. Parent, Nathan Carl Schultheiss, Melanie Janelle Bevill, Petinka Vlahova, Travis L. Houston
  • Forms of rifaximin and uses thereof
    Patent number: 8513275
    Abstract: The present invention relates to new rifaximin forms kappa, theta, rifaximin:piperazine cocrystal 1 and rifaximin:piperazine cocrystal 2, methods of making same and to their use in medicinal preparations and therapeutic methods.
    Type: Grant
    Filed: June 3, 2011
    Date of Patent: August 20, 2013
    Assignee: Salix Pharmaceuticals, Ltd
    Inventors: Yiduo Wu, Stephan D. Parent, Nathan Carl Schultheiss, Melanie Janelle Bevill, Petinka Vlahova, Travis L. Houston
  • FORMS OF RIFAXIMIN AND USES THEREOF
    Publication number: 20120108620
    Abstract: The present invention relates to new rifaximin forms kappa, theta, rifaximin:piperazine cocrystal 1 and rifaximin:piperazine cocrystal 2, methods of making same and to their use in medicinal preparations and therapeutic methods.
    Type: Application
    Filed: June 3, 2011
    Publication date: May 3, 2012
    Applicant: SALIX PHARMACEUTICALS, LTD.
    Inventors: Yiduo Wu, Stephan D. Parent, Nathan Carl Schultheiss, Melanie Janelle Bevill, Petinka Vlahova, Travis L. Houston